Tango Therapeutics (TNGX) Operating Margin (QoQ) (2020 - 2025)

Tango Therapeutics (TNGX) Operating Margin (QoQ) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Tango Therapeutics 3.94 Bn 3.78 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2025 131,402.00
Jun 30, 2025 -49,910.00
Mar 31, 2025 20,492.00
Dec 31, 2024 -71,042.00
Sep 30, 2024 -13,457.00
Jun 30, 2024 50,430.00
Mar 31, 2024 -830.00
Dec 31, 2023 -40,591.00
Sep 30, 2023 -7,953.00
Jun 30, 2023 36,600.00
Mar 31, 2023 -4,846.00
Dec 31, 2022 -4,438.00
Sep 30, 2022 429.00
Jun 30, 2022 406.00
Mar 31, 2022 -5,616.00
Dec 31, 2021 -9,627.00
Sep 30, 2021 -26,323.00
Jun 30, 2021 16,408.00
Mar 31, 2021 -18,624.00
Dec 31, 2020 23,466.00